Myeloid Leukemia, Chronic, Chronic Phase
Also known as: Leukemia, Myeloid, Chronic-Phase (CML-CP) / Chronic Myeloid Leukemia in Chronic Phase / Chronic Phase of Chronic Myeloid Leukemia / Myeloid Leukemia, Chronic, Chronic-Phase / Leukemia, Myeloid, Chronic Phase / Chronic Phase-Chronic Myeloid Leukemia / Leukemia, Myeloid, Chronic-Phase / Chronic Myeloid Leukemia, Chronic Phase / Chronic Phase Chronic Myeloid Leukemia / Chronic Myeloid Leukemia - Chronic Phase / Leukemia, Myelogenous, Chronic Phase / Myelogenous Leukemia, Chronic, Chronic Phase / Chronic Myelogenous Leukemia - Chronic Phase / Chronic Phase Chronic Myelogenous Leukemia / Chronic phase chronic myeloid leukemia (disorder) / Chronic phase chronic myeloid leukaemia / Chronic myeloid leukemia (morphologic abnormality) / Myeloid leukemia, chronic / Chronic myeloid leukemia, disease (disorder) / Chronic myelogenous leukemia, no ICD-O subtype (morphologic abnormality) / Chronic myeloid leukaemia / Chronic myeloid leukemia / CML / Chronic myelogenous leukaemia / Chronic myelocytic leukaemia / Leukemia myelocytic chronic / Chronic myelogenous leukemia / Leukaemia myelocytic chronic / Chronic granulocytic leukemia / Leukaemias chronic myeloid / Chronic myelocytic leukemia / Chronic granulocytic leukaemia / Myeloid leukaemia, chronic / Chronic myeloid leukemia NOS (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB12597 | Asciminib | An inhibitor of ABL/BCR-ABL1 tyrosine kinase for the treatment of patients with Philadelphia chromosome-positive CML, including those with the T315I mutation. |
DB06616 | Bosutinib | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. |
DB01254 | Dasatinib | A tyrosine kinase inhibitor used for the treatment of lymphoblastic or chronic myeloid leukemia with resistance or intolerance to prior therapy. |
DB00694 | Daunorubicin | An anthracycline aminoglycoside used to induce remission of nonlymphocytic leukemia and acute lymphocytic leukemia. |
DB04868 | Nilotinib | A kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib. |
DB08901 | Ponatinib | A kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML). |